Abivax (ABVX.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | ||
| Depreciation Amortization | 136 | N/A |
| Accounts receivable | 1,522 | N/A |
| Accounts payable and accrued liabilities | 1,759 | -4,268 |
| Other Working Capital | 3,355 | N/A |
| Other Operating Activity | -21,676 | 963 |
| Operating Cash Flow | $-14,904 | $-3,305 |
| Cash Flows From Investing Activities | ||
| PPE Investments | 202 | N/A |
| Sale Of Investment | 2 | N/A |
| Other Investing Activity | -1,220 | -43 |
| Investing Cash Flow | $-1,016 | $-43 |
| Cash Flows From Financing Activities | ||
| Debt Issued | 2,000 | 45 |
| Debt Repayment | N/A | -124 |
| Other Financing Activity | 50,126 | 6,020 |
| Financing Cash Flow | $52,126 | $5,941 |
| Beginning Cash Position | 2,921 | 40 |
| End Cash Position | 39,127 | 2,921 |
| Net Cash Flow | $36,206 | $2,593 |
| Free Cash Flow | ||
| Operating Cash Flow | -14,904 | -3,305 |
| Capital Expenditure | -1,025 | -43 |
| Free Cash Flow | -15,929 | -3,348 |